Scarica l'app Stockscreener
10.31
2.38%
0.24
Dopo l'orario di chiusura:
10.29
-0.02
-0.19%
Xeris Biopharma Holdings Inc Borsa (XERS) Ultime notizie
Form 4 Xeris Biopharma Holdings, Inc: Steven Pieper (Officer) For: 1 October - Investing.com Nigeria
Xeris Biopharma CFO Steven Pieper sells $47,036 in stock By Investing.com - Investing.com Canada
Xeris Biopharma CLO Beth Hecht sells $156,792 in XERS shares - Investing.com
Xeris Biopharma COO McCulloch sells $141,120 in shares - Investing.com
Insider Sell Alert: Beth Hecht Sells 16,666 Shares of Xeris Biop - GuruFocus
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
An officer plans a $159K share sale at Xeris Biopharma (XERS). - Stock Titan
Xeris Biopharma Holdings Insider Sold Shares Worth $250,000, According to a Recent SEC Filing - Yahoo Finance
A Xeris Biopharma (XERS) officer proposes a share sale valued at $637,000. - Stock Titan
Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: A 50% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews
Xeris Biopharma Holdings, Inc. (XERS) Discusses XP-8121 Program Overview, Phase 3 Study Details and Commercial StrategySlideshow (NASDAQ:XERS) 2026-09-11 - Seeking Alpha
XERS Maintained by Leerink Partners -- Price Target Raised to $1 - GuruFocus
Oppenheimer reiterates Xeris Pharmaceuticals stock rating on XP-8121 outlook - Investing.com Nigeria
Oppenheimer reiterates Xeris Pharmaceuticals stock rating on XP-8121 outlook - Investing.com Canada
Xeris Biopharma Holdings (NasdaqGS:XERS) Stock Forecast & Analyst Predictions - Simply Wall Street
symbol__ Stock Quote Price and Forecast - cnn.com
Xeris Biopharma Holdings, Inc. (XERS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Xeris Biopharma Holdings, Inc. at XP-8121 Program Overview Transcript - GuruFocus
XERS Looks 54.7% Overvalued on GF Value™ as Clinical Update Appr - GuruFocus
Millions of thyroid patients may get weekly shot option from Xeris (NASDAQ: XERS) - Stock Titan
Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism - businesswire.com
An estimated 3 to 5 million lack thyroid control. Xeris is developing a weekly injection. - Stock Titan
Xeris Biopharma Holdings Inc. (XERS) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Xeris Biopharma CFO Steven Pieper sells $42,500 in shares By Investing.com - Investing.com South Africa
Xeris Biopharma COO Kevin McCulloch sells $127,308 in stock - Investing.com India
Xeris Biopharma’s Beth Hecht sells $141,434 in company stock By Investing.com - Investing.com India
Xeris Biopharma CFO Steven Pieper sells $42,500 in shares By Investing.com - Investing.com India
Xeris Biopharma CFO Steven Pieper sells $42,500 in shares - Investing.com
Xeris Biopharma CFO Steven Pieper sells $42,500 in shares By Investing.com - Investing.com Australia
Xeris Biopharma COO Kevin McCulloch sells $127,308 in stock By Investing.com - Investing.com Canada
Xeris Biopharma COO Kevin McCulloch sells $127,308 in stock By Investing.com - Investing.com Nigeria
Xeris Biopharma’s Beth Hecht sells $141,434 in company stock By Investing.com - Investing.com Canada
Xeris Biopharma’s Beth Hecht sells $141,434 in company stock - Investing.com
Xeris Biopharma CFO Steven Pieper Executes Sale of 5,000 Shares via 10b5-1 Trading Plan - Kalkine Media
Xeris Biopharma CLO Beth Hecht Sells 16,666 Shares via 10b5-1 Trading Plan - kalkinemedia.com
Xeris Biopharma COO Kevin McCulloch Sells 15,000 Shares via 10b5-1 Trading Plan - Kalkine Media
Xeris Biopharma COO Kevin McCulloch sells $127,308 in stock By Investing.com - Investing.com Australia
Xeris Biopharma CFO Steven Pieper sells $42,500 in shares By Investing.com - Investing.com UK
Xeris Biopharma Holdings Inc. (XERS) Peer Comparison – Compare with Others - Value Research
Xeris Biopharma COO Kevin McCulloch sells $127,308 in stock - Investing.com
Xeris Biopharma stock holds at $8.48 after earnings miss - ad-hoc-news.de
XERS Stock Price, Quote & News - Syfe
Xeris Biopharma Holdings Inc. (XERS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Xeris Biopharma Holdings, Inc. (0A8E.L) Stock Price, News, Quote & History - Yahoo Finance
Xeris Announces Details for XP-8121 Program Overview Webinar - Yahoo Finance
Xeris (XERS) Earnings Report: Profit Per Share Falls Below Its Benchmark in the Available Record; Price Reaction - vinanet.vn
XERS | Xeris Biopharma Holdings, Inc. FinancialsRevenue Breakdown - Quiver Quantitative
Xeris Biopharma CEO John Patrick Shannon Jr. Reports Share Withholding for RSU Tax Settlement - Kalkine Media
XERS Maintains Overweight Rating by Barclays -- Price Target Rai - GuruFocus
Xeris Biopharma: A Commercial Stage Pharma That May Be A Slow-Burn Buy Opportunity (XERS) - Seeking Alpha
2.82%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):